All results

1 results for natural history study development type 1 diabetes

• ITN095AI DESIGNATE

  This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis.…

  Ages

  8 Years - 45 Years

  Sexes

  All